JP2005330251A5 - - Google Patents

Download PDF

Info

Publication number
JP2005330251A5
JP2005330251A5 JP2004152144A JP2004152144A JP2005330251A5 JP 2005330251 A5 JP2005330251 A5 JP 2005330251A5 JP 2004152144 A JP2004152144 A JP 2004152144A JP 2004152144 A JP2004152144 A JP 2004152144A JP 2005330251 A5 JP2005330251 A5 JP 2005330251A5
Authority
JP
Japan
Prior art keywords
mass
composition
liquid oral
potassium ion
oral cavity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004152144A
Other languages
Japanese (ja)
Other versions
JP2005330251A (en
JP4398301B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2004152144A priority Critical patent/JP4398301B2/en
Priority claimed from JP2004152144A external-priority patent/JP4398301B2/en
Publication of JP2005330251A publication Critical patent/JP2005330251A/en
Publication of JP2005330251A5 publication Critical patent/JP2005330251A5/ja
Application granted granted Critical
Publication of JP4398301B2 publication Critical patent/JP4398301B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (5)

カリウムイオン供給化合物、アシルタウリン塩、有機酸又はその塩及び水を含有し、かつpH５〜８である液体口腔用組成物。   A liquid oral composition containing a potassium ion supply compound, an acyl taurine salt, an organic acid or a salt thereof and water, and having a pH of 5-8. 下記成分（Ａ）、（Ｂ）、（Ｃ）及び（Ｄ）：
（Ａ）カリウムイオン供給化合物 カリウムイオンとして０．０１質量％以上
（Ｂ）アシルタウリン塩 ０．０１〜５質量％
（Ｃ）有機酸又はその塩 ０．０５〜５質量％
（Ｄ）水 ６０〜９８質量％
を含有し、かつpH５〜８である液体口腔用組成物。 The following components (A), (B), (C) and (D):
(A) Potassium ion supply compound 0.01 mass% or more as potassium ion (B) Acyl taurine salt 0.01-5 mass%
(C) Organic acid or its salt 0.05-5 mass%
(D) Water 60-98 mass%
And a composition for liquid oral cavity which has a pH of 5-8. 下記成分（Ａ）、（Ｂ）、（Ｃ）及び（Ｄ）：
（Ａ）カリウムイオン供給化合物 カリウムイオンとして０．０１質量％以上
（Ｂ）アシルタウリン塩 ０．０１〜５質量％
（Ｃ）リンゴ酸、酒石酸、乳酸、クエン酸及びそれらの塩から選ばれる１種又は２種以上
０．０５〜５質量％
（Ｄ）水 ６０〜９８質量％
を含有し、かつpH５〜８である液体口腔用組成物。 The following components (A), (B) , (C) and (D):
(A) Potassium ion supply compound 0.01 mass% or more as potassium ion (B) Acyl taurine salt 0.01-5 mass%
(C) 1 type (s) or 2 or more types chosen from malic acid, tartaric acid, lactic acid, citric acid, and their salts 0.05-5 mass%
(D) Water 60-98 mass%
And a composition for liquid oral cavity which has a pH of 5-8. さらに成分（Ｅ）非イオン界面活性剤を含有する請求項１〜３のいずれかに記載の液体口腔用組成物。   Furthermore, the composition for liquid oral cavity in any one of Claims 1-3 containing a component (E) nonionic surfactant. さらにナトリウムイオンを０．００００１〜０．２質量％含有するものである請求項１〜４のいずれかに記載の液体口腔用組成物。   Furthermore, 0.00001-0.2 mass% sodium ion is contained, The composition for liquid oral cavity in any one of Claims 1-4.
JP2004152144A 2004-05-21 2004-05-21 Liquid oral composition Expired - Fee Related JP4398301B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004152144A JP4398301B2 (en) 2004-05-21 2004-05-21 Liquid oral composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004152144A JP4398301B2 (en) 2004-05-21 2004-05-21 Liquid oral composition

Publications (3)

Publication Number Publication Date
JP2005330251A JP2005330251A (en) 2005-12-02
JP2005330251A5 true JP2005330251A5 (en) 2007-06-07
JP4398301B2 JP4398301B2 (en) 2010-01-13

Family

ID=35485152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004152144A Expired - Fee Related JP4398301B2 (en) 2004-05-21 2004-05-21 Liquid oral composition

Country Status (1)

Country Link
JP (1) JP4398301B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5658888B2 (en) * 2010-02-22 2015-01-28 花王株式会社 Liquid oral composition
JP6118547B2 (en) * 2012-12-10 2017-04-19 花王株式会社 Oral composition

Similar Documents

Publication Publication Date Title
JP2007537301A5 (en)
JP2011516655A5 (en)
NO20065719L (en) Substantially pure 2 - {[2- (2-methylamino-pyrimidin-4-yl) -1H-indol-5-carbonyl] -amino} -3- (phenylpyridin-2-yl-amino) -propionic acid as an IkB kinase inhibitor.
JP2005510538A5 (en)
PE20080741A1 (en) PARENTERAL FORMULATIONS OF METHYLNALTREXONE AND ITS SALTS
CY1113011T1 (en) NEW Crystalline Form V of Agomelatin, Its Preparation Method and Pharmaceutical Compositions Containing It
CL2004000782A1 (en) PARENTERAL PHARMACEUTICAL COMPOSITION THAT INCLUDES (A) PIPERACILLIN, (B) TAZOBACTAMO, AND A CHELATING AMINOCARBOXYLIC ACID, WHICH ALSO CAN CONTAIN A TAMPON, AS CITRATE, AND OPTIONALLY AN AMINOGLYCOSIDE; PROCEDURES FOR PREPARATION; AND USE
AR051404A1 (en) CLEANING COMPOSITIONS AND DISINFECTANTS
DE502006001853D1 (en) Encased sodium percarbonate particles
ATE519709T1 (en) SODIUM PERCARBONATE PARTICLES WITH A SHELL LAYER CONTAINING THIOSULFATE
AR074541A1 (en) NATURAL SILVER DISINFECTANT COMPOSITIONS
WO2007141635A3 (en) Detergents formulations with low impact on the environment
NO20083027L (en) Controlled release solid formulation
JP2008533183A5 (en)
NO20083708L (en) 4-Phenyl-thiazole-5-carboxylic acid and 4-phenyl-thiazole-5-carboxylmides as PLK1 inhibitors
ATE341605T1 (en) LIQUID DETERGENT AND CLEANING AGENT COMPOSITION
AR062370A1 (en) HERBICIDE COMPOSITION
JP2011504873A5 (en)
BR0317554A (en) Controlled release coated peroxygenated compounds, a process for their preparation and use
JP2011026350A5 (en)
AR075097A1 (en) CRYSTAL POLYMAL SALES AND FORMS OF [4- (6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-IL) -PENYL] -5-CHLORINE-THIOPHEN-2- IL-SULFONIL UREA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, METHOD TO PREPARE THEM AND USE OF THE SAME IN THE TREATMENT OF CARDIOVASCULAR DISEASES ASSOCIATE
JP2009051734A5 (en)
JP2005330251A5 (en)
EA201000701A1 (en) 4- [4- (2-ADAMANTHYLKARBAMOIL) -5-TRET-BUTYL-Pyrazole-1-IL] BENZOIC ACID-465
IL189915A0 (en) Use of inhibitors of the na+/h+exchanger, subtype 5 (nhe5), to improve memory retention